Rockwell Medical (RMTI) Total Debt Growth (3y) (2021 - 2026)
Rockwell Medical (RMTI) Total Debt Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -7.03% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.29% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -58.89% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -12.80% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 72.82% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -4.66% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Rockwell Medical | 26.01 Mn | 2.12 Mn | 2.90 Mn | -1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.33% |
| Dec 31, 2025 | 5.32% |
| Sep 30, 2025 | -9.24% |
| Jun 30, 2025 | -10.41% |
| Mar 31, 2025 | -15.79% |
| Dec 31, 2024 | -19.22% |
| Sep 30, 2024 | -8.90% |
| Mar 31, 2024 | -20.24% |
| Dec 31, 2023 | -19.83% |
| Sep 30, 2023 | -34.76% |
| Jun 30, 2023 | -23.53% |
| Mar 31, 2023 | -23.63% |
| Dec 31, 2022 | 241.92% |
| Sep 30, 2022 | 313.04% |
| Jun 30, 2022 | 180.82% |
| Mar 31, 2022 | 148.48% |
| Dec 31, 2021 | 129.57% |